KredietR.T., BalafaO.Cardiovascular risk in the peritoneal dialysis patient.Nat Rev Nephrol2010; 6: 451–60.
2.
KredietR.T., StruijkD.G.Peritoneal changes in patients on long-term peritoneal dialysis.Nat Rev Nephrol2013; 9: 419–29.
3.
DaviesS.J.Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.Kidney Int2004; 66: 2437–45.
4.
WilkieM.E., PlantM.J., EdwardsL.E., BrownC.B.Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival.Perit Dial Int1997; 17: 84–7.
5.
MujaisS., NolphK., GokalR., BlakeP., BurkartJ., ColesG.Evaluation and management of ultrafiltration problems in peritoneal dialysis.Perit Dial Int2000; 20(Suppl 4): S5–21.
6.
MactierR.A., KhannaR., TwardowskiZ.J., NolphK.D.Ultra-filtration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption.Am J Kidney Dis1987; 10: 461–6.
7.
SzetoC.C., LawM.C., WongT.Y.H., LeungC.B., LiP.K.T.Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.Am J Kidney Dis2001; 37: 329–36.
8.
RumpsfeldM., McDonaldS.P., PurdieD.M., CollinsJ., JohnsonD.W.Predictors of baseline peritoneal transport status in Australian and New Zealand dialysis patients.Am J Kidney Dis2004; 43: 492–501.
9.
ZemelD., ten BergeR.J.M., StruijkD.G., BloemenaE., KoomenG.C.M., KredietR.T.Interleukin-6 in CAPD patients without peritonitis. Relationship to the intrinsic permeability of the peritoneal membrane.Clin Nephrol1992; 37: 97–103.
10.
Pecoits-FilhoR., AraújoM.R., LindholmB., StenvinkelP., AbensurH., RomãoJ.E.Jr.Plasma and dialysate Il-6 and VEGF concentrations are associated with high peritoneal solute transport rate.Nephrol Dial Transplant2002; 17: 1480–6.
11.
RodriguesA., MartinsM., SantosM.J., FonsecaI., OliveiraJ.C., CabritaA.Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor and interleukin-6: Relationship with peritoneal transport.Adv Perit Dial2004; 20: 8–12.
12.
Van EschS., ZweersM.M., JansenM.A.M., De WaartD.R., Van MaanenJ.G., KredietR.T.Determinants of peritoneal solute transport in newly started nondiabetic peritoneal dialysis patients.Perit Dial Int2004; 24: 554–61.
13.
VisserC.E., Brouwer-SteenbergenJ.J., BetjesM.G., KoomenG.C., BeelenR.H., KredietR.T.Cancer antigen 125: a bulk marker for for the mesothelial mass in stable peritoneal dialysis patients.Nephrol Dial Transplant1995; 10: 64–9.
14.
SelgasR., del PesoG., BajoM.A., CastroM.A., MolinaS., CirugedaA.Spontaneous VEGF production by cultured mesotelial cells from patients on peritoneal dialysis.Perit Dial Int2000; 20: 798–801.
15.
TopleyN., JörresA., LuttmannW., PetersenM.M., LangM.J., ThierauchK.H.Human peritoneal mesothelial cells synthesize IL-6: induction by IL-1beta and TNFalpha.Kidney Int1993; 43: 226–33.
16.
Yáñez-MóM., Lara-PezziE., SelgasR., Ramírez-HuescaR., Domínguez-JiménezC.Peritoneal dialysis and epithelial-to-mesenchymal trasition of mesothelial cells.N Engl J Med2003; 348: 403–13.
17.
AroeiraL.S., AguileraA., Sánchez-TomeroJ.A., BajoM.A., del PesoG., Jiménez-HeffernanJ.A.Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.J Am Soc Nephrol2007; 18: 2004–13.
18.
AroeiraL.S., AguileraA., SelgasR., Ramírez-HuescaM., Pérez-LozanoM.L., CirugedaA.Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport in peritoneal dialysis: role of vascular endothelial growth factor.Am J Kidney Dis2005; 46: 938–48.
19.
Del PesoG., Jiménez-HeffernanJ.A., BajoM.A., AroeiraL.S., AguileraA., Fernández-PerpénA.Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.Kidney Int2008; 73: S26–33.
20.
MirandaB., SelgasR., CeladillaO., MunozJ., Sanchez-SiciliaL.Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in patients on CAPD.Contr Nephrol1991; 89: 199–204.
21.
De SousaE., Del PesoG., AlvarezL., RosS., MateusA., AguilarA.Peritoneal resting with heparinized lavage reverses peritoneal type I membrane failure. A comparative study of the resting effects on normal membranes.Perit Dial Int2014; 34: 698–705.
22.
CoesterA.M., SmitW., StruijkD.G., ParikovaA., KredietR.T.Longitudinal analysis of fluid transport and their determinants in PD ptients.Perit Dial Int2014; 34: 195–203.
